Cargando…
Therapeutic Effects of hiPSC-Derived Glial and Neuronal Progenitor Cells-Conditioned Medium in Experimental Ischemic Stroke in Rats
Transplantation of various types of stem cells as a possible therapy for stroke has been tested for years, and the results are promising. Recent investigations have shown that the administration of the conditioned media obtained after stem cell cultivation can also be effective in the therapy of the...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125106/ https://www.ncbi.nlm.nih.gov/pubmed/33946667 http://dx.doi.org/10.3390/ijms22094694 |
_version_ | 1783693403253374976 |
---|---|
author | Salikhova, Diana Bukharova, Tatiana Cherkashova, Elvira Namestnikova, Daria Leonov, Georgy Nikitina, Maria Gubskiy, Ilya Akopyan, Gevorg Elchaninov, Andrey Midiber, Konstantin Bulatenco, Natalia Mokrousova, Victoria Makarov, Andrey Yarygin, Konstantin Chekhonin, Vladimir Mikhaleva, Liudmila Fatkhudinov, Timur Goldshtein, Dmitry |
author_facet | Salikhova, Diana Bukharova, Tatiana Cherkashova, Elvira Namestnikova, Daria Leonov, Georgy Nikitina, Maria Gubskiy, Ilya Akopyan, Gevorg Elchaninov, Andrey Midiber, Konstantin Bulatenco, Natalia Mokrousova, Victoria Makarov, Andrey Yarygin, Konstantin Chekhonin, Vladimir Mikhaleva, Liudmila Fatkhudinov, Timur Goldshtein, Dmitry |
author_sort | Salikhova, Diana |
collection | PubMed |
description | Transplantation of various types of stem cells as a possible therapy for stroke has been tested for years, and the results are promising. Recent investigations have shown that the administration of the conditioned media obtained after stem cell cultivation can also be effective in the therapy of the central nervous system pathology (hypothesis of their paracrine action). The aim of this study was to evaluate the therapeutic effects of the conditioned medium of hiPSC-derived glial and neuronal progenitor cells in the rat middle cerebral artery occlusion model of the ischemic stroke. Secretory activity of the cultured neuronal and glial progenitor cells was evaluated by proteomic and immunosorbent-based approaches. Therapeutic effects were assessed by overall survival, neurologic deficit and infarct volume dynamics, as well as by the end-point values of the apoptosis- and inflammation-related gene expression levels, the extent of microglia/macrophage infiltration and the numbers of formed blood vessels in the affected area of the brain. As a result, 31% of the protein species discovered in glial progenitor cells-conditioned medium and 45% in neuronal progenitor cells-conditioned medium were cell type specific. The glial progenitor cell-conditioned media showed a higher content of neurotrophins (BDNF, GDNF, CNTF and NGF). We showed that intra-arterial administration of glial progenitor cells-conditioned medium promoted a faster decrease in neurological deficit compared to the control group, reduced microglia/macrophage infiltration, reduced expression of pro-apoptotic gene Bax and pro-inflammatory cytokine gene Tnf, increased expression of anti-inflammatory cytokine genes (Il4, Il10, Il13) and promoted the formation of blood vessels within the damaged area. None of these effects were exerted by the neuronal progenitor cell-conditioned media. The results indicate pronounced cytoprotective, anti-inflammatory and angiogenic properties of soluble factors secreted by glial progenitor cells. |
format | Online Article Text |
id | pubmed-8125106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81251062021-05-17 Therapeutic Effects of hiPSC-Derived Glial and Neuronal Progenitor Cells-Conditioned Medium in Experimental Ischemic Stroke in Rats Salikhova, Diana Bukharova, Tatiana Cherkashova, Elvira Namestnikova, Daria Leonov, Georgy Nikitina, Maria Gubskiy, Ilya Akopyan, Gevorg Elchaninov, Andrey Midiber, Konstantin Bulatenco, Natalia Mokrousova, Victoria Makarov, Andrey Yarygin, Konstantin Chekhonin, Vladimir Mikhaleva, Liudmila Fatkhudinov, Timur Goldshtein, Dmitry Int J Mol Sci Article Transplantation of various types of stem cells as a possible therapy for stroke has been tested for years, and the results are promising. Recent investigations have shown that the administration of the conditioned media obtained after stem cell cultivation can also be effective in the therapy of the central nervous system pathology (hypothesis of their paracrine action). The aim of this study was to evaluate the therapeutic effects of the conditioned medium of hiPSC-derived glial and neuronal progenitor cells in the rat middle cerebral artery occlusion model of the ischemic stroke. Secretory activity of the cultured neuronal and glial progenitor cells was evaluated by proteomic and immunosorbent-based approaches. Therapeutic effects were assessed by overall survival, neurologic deficit and infarct volume dynamics, as well as by the end-point values of the apoptosis- and inflammation-related gene expression levels, the extent of microglia/macrophage infiltration and the numbers of formed blood vessels in the affected area of the brain. As a result, 31% of the protein species discovered in glial progenitor cells-conditioned medium and 45% in neuronal progenitor cells-conditioned medium were cell type specific. The glial progenitor cell-conditioned media showed a higher content of neurotrophins (BDNF, GDNF, CNTF and NGF). We showed that intra-arterial administration of glial progenitor cells-conditioned medium promoted a faster decrease in neurological deficit compared to the control group, reduced microglia/macrophage infiltration, reduced expression of pro-apoptotic gene Bax and pro-inflammatory cytokine gene Tnf, increased expression of anti-inflammatory cytokine genes (Il4, Il10, Il13) and promoted the formation of blood vessels within the damaged area. None of these effects were exerted by the neuronal progenitor cell-conditioned media. The results indicate pronounced cytoprotective, anti-inflammatory and angiogenic properties of soluble factors secreted by glial progenitor cells. MDPI 2021-04-29 /pmc/articles/PMC8125106/ /pubmed/33946667 http://dx.doi.org/10.3390/ijms22094694 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Salikhova, Diana Bukharova, Tatiana Cherkashova, Elvira Namestnikova, Daria Leonov, Georgy Nikitina, Maria Gubskiy, Ilya Akopyan, Gevorg Elchaninov, Andrey Midiber, Konstantin Bulatenco, Natalia Mokrousova, Victoria Makarov, Andrey Yarygin, Konstantin Chekhonin, Vladimir Mikhaleva, Liudmila Fatkhudinov, Timur Goldshtein, Dmitry Therapeutic Effects of hiPSC-Derived Glial and Neuronal Progenitor Cells-Conditioned Medium in Experimental Ischemic Stroke in Rats |
title | Therapeutic Effects of hiPSC-Derived Glial and Neuronal Progenitor Cells-Conditioned Medium in Experimental Ischemic Stroke in Rats |
title_full | Therapeutic Effects of hiPSC-Derived Glial and Neuronal Progenitor Cells-Conditioned Medium in Experimental Ischemic Stroke in Rats |
title_fullStr | Therapeutic Effects of hiPSC-Derived Glial and Neuronal Progenitor Cells-Conditioned Medium in Experimental Ischemic Stroke in Rats |
title_full_unstemmed | Therapeutic Effects of hiPSC-Derived Glial and Neuronal Progenitor Cells-Conditioned Medium in Experimental Ischemic Stroke in Rats |
title_short | Therapeutic Effects of hiPSC-Derived Glial and Neuronal Progenitor Cells-Conditioned Medium in Experimental Ischemic Stroke in Rats |
title_sort | therapeutic effects of hipsc-derived glial and neuronal progenitor cells-conditioned medium in experimental ischemic stroke in rats |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125106/ https://www.ncbi.nlm.nih.gov/pubmed/33946667 http://dx.doi.org/10.3390/ijms22094694 |
work_keys_str_mv | AT salikhovadiana therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT bukharovatatiana therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT cherkashovaelvira therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT namestnikovadaria therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT leonovgeorgy therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT nikitinamaria therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT gubskiyilya therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT akopyangevorg therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT elchaninovandrey therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT midiberkonstantin therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT bulatenconatalia therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT mokrousovavictoria therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT makarovandrey therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT yaryginkonstantin therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT chekhoninvladimir therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT mikhalevaliudmila therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT fatkhudinovtimur therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats AT goldshteindmitry therapeuticeffectsofhipscderivedglialandneuronalprogenitorcellsconditionedmediuminexperimentalischemicstrokeinrats |